Bicara Therapeutics (BCAX) EPS (Basic) (2023 - 2026)
Bicara Therapeutics' (BCAX) quarterly EPS (Basic) came in at -$0.93 in Q1 2026, down 36.83% year-on-year from -$1.47 in Q1 2025, and down 135295.92% quarter-over-quarter from -$0.0 in Q4 2025.
Bicara Therapeutics (BCAX) EPS (Basic) (2023 - 2026) Analysis & Trends
Bicara Therapeutics' EPS (Basic) history runs 4 years deep, the most recent figure standing at -$0.93 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 36.83% year-over-year to -$0.93 in Q1 2026; TTM through Mar 2026 was -$2.59, a 52.81% decrease from a year earlier, with the FY2025 full-year figure at -$0.0, up 37.64% from the prior year.
- EPS (Basic) declined to -$0.93 in Q1 2026 per BCAX's latest filing, from -$0.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.0 in Q4 2025 and bottomed at -$38.23 in Q3 2023.
- The 4-year median for EPS (Basic) is -$0.68 (2025), against an average of -$7.33.
- Across the five-year window, EPS (Basic) jumped 97.36% in 2025 and plunged 36.83% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$0.02 in 2023, then soared by 94.18% to -$0.0 in 2024, then soared by 45.17% to -$0.0 in 2025, then slumped by 135295.92% to -$0.93 in 2026.
- Per Business Quant, the three latest BCAX EPS (Basic) figures stand at -$0.93 (Q1 2026), -$0.0 (Q4 2025), and -$0.67 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Bicara Therapeutics | 1.64 Bn | 1.64 Bn | - | -0.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.93 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -0.67 |
| Jun 30, 2025 | -0.50 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -1.60 |
| Jun 30, 2024 | -19.01 |
| Mar 31, 2024 | -18.94 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -38.23 |